跳至主要内容
临床试验/NL-OMON30579
NL-OMON30579尚未招募不适用

Sodium Oxybate for the Treatment of Vigilance Impairment in Narcolepsy - Sodium Oxybate and Vigilance in Narcolepsy

Academisch Medisch Centrum0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Definite narcolepsy-cataplexy, according to international criteria [AASM 2005],
  • - Patients have to be treatment-naive and planning to start sodium oxybate or already using sodium oxybate and prepared to stop medication at least 14 days prior to study start

排除标准

  • - Younger than 18 or older than 70 years
  • - Cognitive impairment due to neurological disorders other than sleep-wake disorders
  • - Use of other hypnotics or other sleep-wake active drugs

研究者

相似试验

尚未招募
3 期
Sodium-oxybate as a potential new treatment for catatonia in patients with depression, bipolar disorder or a psychotic disorder, a randomized controlled trial. The Laborit study.KatatonieCatatoniasyndrome associated with psychomotor disturbanceswith either a retarded or excited nature10037176
NL-OMON56950Amsterdam UMC42
尚未招募
3 期
Sodium-oxybate as a potential new treatment for catatonia in patients with depression, bipolar disorder or a psychotic disorder, a randomized controlled trial. The Laborit study.KatatonieCatatoniasyndrome associated with psychomotor disturbanceswith either a retarded or excited nature10037176
NL-OMON54182Amsterdam UMC42
进行中(未招募)
3 期
Sodium oxybate as a potential new treatment for catatonia in patients with depression, bipolar disorder or a psychotic disorderTreatment of catatonia in adult patients with unipolar depression, bipolar disorder or psychotic disorders, that do not sufficiently benefit from treatment with lorazepam.Mental and Behavioural Disorders
ISRCTN11236443Amsterdam UMC Location VUmc42
进行中(未招募)
1 期
Efficacy and safety of Sodium Oxybate in reducing alcohol consumption and maintaining abstinence in alcohol-dependent subjects with high and very high drinking risk levelAlcohol addiction
CTIS2023-506990-37-00aboratorio Farmaceutico C.T. S.r.l.51
进行中(未招募)
1 期
OXYTAHANE - Oxygen therapy: Acute Treatment for paroxysmal dystonic or plegic attacks in alternating hemiplegia of childhoodAlternating Hemiplegia of Childhood
CTIS2023-508413-16-00Assistance Publique Hopitaux De Paris24
Sodium Oxybate for the Treatment of Vigilance... | 临床试验